Agilon Health (NYSE:AGL) Stock Price Up 9% – Still a Buy?

Agilon Health, Inc. (NYSE:AGL)’s share price rose 9% on Tuesday . The stock traded as high as $64.00 and last traded at $64.9740. Approximately 342,027 shares were traded during trading, a decline of 6% from the average daily volume of 362,779 shares. The stock had previously closed at $59.61.

Wall Street Analysts Forecast Growth

AGL has been the subject of several recent analyst reports. Barclays lowered their target price on shares of Agilon Health from $25.00 to $12.50 and set an “underweight” rating for the company in a research note on Friday, February 27th. Wall Street Zen raised Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday. Benchmark lifted their target price on Agilon Health to $13.00 and gave the stock a “buy” rating in a report on Thursday, April 2nd. Deutsche Bank Aktiengesellschaft raised Agilon Health from a “hold” rating to a “buy” rating and boosted their target price for the company from $33.00 to $49.00 in a research note on Thursday, May 7th. Finally, JPMorgan Chase & Co. lowered Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price target on the stock. in a research report on Monday, May 4th. Five investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, Agilon Health has an average rating of “Hold” and a consensus target price of $39.48.

Agilon Health Stock Performance

The stock’s 50 day moving average is $20.54 and its two-hundred day moving average is $18.71. The stock has a market capitalization of $1.18 billion, a price-to-earnings ratio of -3.27 and a beta of 2.29. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.76. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%. Analysts expect that Agilon Health, Inc. will post -5.58 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Agilon Health

Several hedge funds have recently made changes to their positions in the business. Wealthcare Advisory Partners LLC bought a new stake in shares of Agilon Health in the third quarter worth $26,000. LPL Financial LLC grew its position in Agilon Health by 213.4% in the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after purchasing an additional 30,000 shares in the last quarter. Krilogy Financial LLC acquired a new stake in Agilon Health in the 4th quarter valued at $34,000. CIBC Bancorp USA Inc. bought a new stake in Agilon Health during the 3rd quarter worth about $34,000. Finally, Merit Financial Group LLC bought a new stake in Agilon Health during the 4th quarter worth about $35,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.